PubMed:27172902 / 1704-1942 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T9","span":{"begin":0,"end":238},"obj":"Sentence"}],"text":"Taken together, our results suggest that cisplatin induces immune-suppressive tolerogenic DCs in TLR agonist-induced inflammatory conditions via abundant IL-10 production, thereby skewing Th cell differentiation towards Th2 and Tr1 cells."}

{"project":"LitCoin-entities","denotations":[{"id":"11319","span":{"begin":41,"end":50},"obj":"ChemicalEntity"},{"id":"11320","span":{"begin":97,"end":108},"obj":"ChemicalEntity"},{"id":"11321","span":{"begin":117,"end":129},"obj":"DiseaseOrPhenotypicFeature"},{"id":"11322","span":{"begin":154,"end":159},"obj":"GeneOrGeneProduct"}],"attributes":[{"id":"A40","pred":"db_id","subj":"11319","obj":"MESH:D002945"},{"id":"A41","pred":"db_id","subj":"11321","obj":"MESH:D007249"},{"id":"A42","pred":"db_id","subj":"11322","obj":"NCBIGene:16153"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Taken together, our results suggest that cisplatin induces immune-suppressive tolerogenic DCs in TLR agonist-induced inflammatory conditions via abundant IL-10 production, thereby skewing Th cell differentiation towards Th2 and Tr1 cells."}

{"project":"LitCoin_Mondo","denotations":[{"id":"T2","span":{"begin":59,"end":77},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"0007816"}],"text":"Taken together, our results suggest that cisplatin induces immune-suppressive tolerogenic DCs in TLR agonist-induced inflammatory conditions via abundant IL-10 production, thereby skewing Th cell differentiation towards Th2 and Tr1 cells."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T57","span":{"begin":41,"end":50},"obj":"GeneOrGeneProduct"},{"id":"T58","span":{"begin":51,"end":58},"obj":"GeneOrGeneProduct"},{"id":"T59","span":{"begin":59,"end":65},"obj":"GeneOrGeneProduct"},{"id":"T60","span":{"begin":109,"end":116},"obj":"GeneOrGeneProduct"},{"id":"T61","span":{"begin":154,"end":159},"obj":"GeneOrGeneProduct"},{"id":"T62","span":{"begin":160,"end":170},"obj":"GeneOrGeneProduct"},{"id":"T63","span":{"begin":191,"end":211},"obj":"GeneOrGeneProduct"},{"id":"T64","span":{"begin":228,"end":231},"obj":"GeneOrGeneProduct"},{"id":"T65","span":{"begin":232,"end":237},"obj":"GeneOrGeneProduct"}],"text":"Taken together, our results suggest that cisplatin induces immune-suppressive tolerogenic DCs in TLR agonist-induced inflammatory conditions via abundant IL-10 production, thereby skewing Th cell differentiation towards Th2 and Tr1 cells."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T32","span":{"begin":41,"end":50},"obj":"GeneOrGeneProduct"},{"id":"T33","span":{"begin":154,"end":159},"obj":"GeneOrGeneProduct"},{"id":"T34","span":{"begin":191,"end":211},"obj":"GeneOrGeneProduct"}],"text":"Taken together, our results suggest that cisplatin induces immune-suppressive tolerogenic DCs in TLR agonist-induced inflammatory conditions via abundant IL-10 production, thereby skewing Th cell differentiation towards Th2 and Tr1 cells."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T2","span":{"begin":117,"end":129},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"originalLabel","subj":"T2","obj":"DISEASE"}],"text":"Taken together, our results suggest that cisplatin induces immune-suppressive tolerogenic DCs in TLR agonist-induced inflammatory conditions via abundant IL-10 production, thereby skewing Th cell differentiation towards Th2 and Tr1 cells."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T20","span":{"begin":97,"end":100},"obj":"GeneOrGeneProduct"},{"id":"T21","span":{"begin":154,"end":159},"obj":"GeneOrGeneProduct"}],"text":"Taken together, our results suggest that cisplatin induces immune-suppressive tolerogenic DCs in TLR agonist-induced inflammatory conditions via abundant IL-10 production, thereby skewing Th cell differentiation towards Th2 and Tr1 cells."}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T13","span":{"begin":90,"end":93},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A13","pred":"mondo_id","subj":"T13","obj":"0010155"}],"text":"Taken together, our results suggest that cisplatin induces immune-suppressive tolerogenic DCs in TLR agonist-induced inflammatory conditions via abundant IL-10 production, thereby skewing Th cell differentiation towards Th2 and Tr1 cells."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T2","span":{"begin":117,"end":129},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"ID:","subj":"T2","obj":"DISEASE"}],"text":"Taken together, our results suggest that cisplatin induces immune-suppressive tolerogenic DCs in TLR agonist-induced inflammatory conditions via abundant IL-10 production, thereby skewing Th cell differentiation towards Th2 and Tr1 cells."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T24","span":{"begin":41,"end":50},"obj":"ChemicalEntity"},{"id":"T26","span":{"begin":97,"end":108},"obj":"ChemicalEntity"}],"attributes":[{"id":"A24","pred":"ID:","subj":"T24","obj":"D002945"},{"id":"A25","pred":"ID:","subj":"T24","obj":"http://purl.obolibrary.org/obo/CHEBI_27899"},{"id":"A26","pred":"ID:","subj":"T26","obj":"ChemicalEntity"}],"text":"Taken together, our results suggest that cisplatin induces immune-suppressive tolerogenic DCs in TLR agonist-induced inflammatory conditions via abundant IL-10 production, thereby skewing Th cell differentiation towards Th2 and Tr1 cells."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T26","span":{"begin":97,"end":108},"obj":"ChemicalEntity"},{"id":"T24","span":{"begin":41,"end":50},"obj":"ChemicalEntity"},{"id":"T21","span":{"begin":154,"end":159},"obj":"GeneOrGeneProduct"},{"id":"T20","span":{"begin":97,"end":100},"obj":"GeneOrGeneProduct"}],"attributes":[{"id":"A26","pred":"ID:","subj":"T26","obj":"ChemicalEntity"},{"id":"A25","pred":"ID:","subj":"T24","obj":"http://purl.obolibrary.org/obo/CHEBI_27899"},{"id":"A24","pred":"ID:","subj":"T24","obj":"D002945"}],"text":"Taken together, our results suggest that cisplatin induces immune-suppressive tolerogenic DCs in TLR agonist-induced inflammatory conditions via abundant IL-10 production, thereby skewing Th cell differentiation towards Th2 and Tr1 cells."}

{"project":"Inflammaging","denotations":[{"id":"T9","span":{"begin":0,"end":238},"obj":"Sentence"},{"id":"T9","span":{"begin":0,"end":238},"obj":"Sentence"}],"text":"Taken together, our results suggest that cisplatin induces immune-suppressive tolerogenic DCs in TLR agonist-induced inflammatory conditions via abundant IL-10 production, thereby skewing Th cell differentiation towards Th2 and Tr1 cells."}